Epidarex Capital is a transatlantic life science venture firm that creates and invests in early-stage therapeutics and medical device companies. The firm focuses on company creation and early-stage investing across the UK and US, partnering with researchers and entrepreneurs to build IP-rich life science businesses and scale innovations from research institutions.
Leadership & Board
Current Number of Employees18
Current LinkedIn Followers4,834
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$145M
Total Amount Raised$145M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$145M
Latest Funding Amount$145M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Epidarex Capital had 18 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
18Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Epidarex Capital had 4,834 followers as of October 5, 2026. The number of followers increased by 41 (0.86%) week-over-week.
4,834Latest Followers Count
41(0.86%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.